Synergy Pharmaceuticals Announces Positive Results in First Phase 3 Trial of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. MU
6. FDX
7. IBM
8. PRIM
9. PFE
10. AWK

Go back to Synergy Pharmaceuticals Announces Positive Results in First Phase 3 Trial of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)

Synergy Pharma (SGYP) Gives Up Early Gains

December 9, 2016 9:52 AM EST

Synergy Pharma (NASDAQ: SGYP) gives up early gains. Shares down fractionally after trading up sharply earlier following positive data.

... More

Synergy Pharma (SGYP) to resume trading at 9AM ET

December 9, 2016 8:45 AM EST

Synergy Pharma (NASDAQ: SGYP) to resume trading at 9AM ET following positive data

... More